Albendazole (Nubend)
Albendazole
Pharmascript Pharmaceuticals Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmascript Pharmaceuticals Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nubend-400 EACH TABLET CONTAINS ALBENDAZOLE 400,0 mg | 400 | A380425A38/12/0425 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Albendazole
- except when intended for the treatment of intestinal parasites, as a single oral dose; (S2)
- except when intended and registered as an anthelmintic in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 5162 to 5165
S2: Albendazole
- when intended for the treatment of intestinal parasites, as a single oral dose; (S4)
- except when intended and registered as an anthelmintic in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 1570 to 1575
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
Drag to rotate. Structure from PubChem CID 2082.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.